NCT03245606View on ClinicalTrials.gov

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease

CompletedOBSERVATIONAL

Enrollment

270

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

July 7, 2020

Study Completion Date

July 7, 2020

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

PROCEDURE

Liver biopsy

Measurement of liver fibrosis

DEVICE

Abdominal MRI

Measurement of liver fibrosis

DEVICE

Transient elastography

Measurement of liver fibrosis

Trial Locations (9)

22027

CH de Saint Brieuc, Saint-Brieuc

31059

CHU de Toulouse, Toulouse

33604

CHU de Bordeaux, Bordeaux

35033

CHU de Rennes, Rennes

44035

CHU de Nantes, Nantes

49933

CHU d'Angers, Angers

56000

Centre Hospitalier Bretagne Atlantique, Vannes

56100

Groupe Hospitalier Bretagne Sud, Lorient

85925

CHD Vendée, La Roche-sur-Yon

All Listed Sponsors

lead

Rennes University Hospital

OTHER

NCT03245606 - Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter